Why the study?
Complete occlusion with ER-REBOA can cause distal ischemia beyond 30 minutes, prompting development of the pREBOA-PRO catheter to evaluate whether longer partial occlusion times reduce acute kidney injury and mortality.
Key points are not available for this paper at this time.
Comparison
pREBOA-PRO with partial occlusion vs ER-REBOA with complete occlusion
Design
Retrospective registry analysis
Answers are grounded in this paper and cite their sources.
May support extended pREBOA-PRO use to limit ischemia; leaves open survival benefit in torso hemorrhage.
Background: Noncompressible torso hemorrhage remains a leading cause of potentially preventable deaths. Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) has emerged as an adjunct temporizing hemorrhage control. The complete occlusion strategy with the ER-REBOA catheter can cause distal ischemia when used for longer than 30 min. To specifically address this limitation, the pREBOA-PRO catheter was developed. The objective of the current study is to investigate the impact of longer, partial occlusion times provided by pREBOA-PRO on acute kidney injury and mortality. Methods: This is a retrospective analysis of the Aortic Occlusion for Resuscitation in Trauma and Acute Care Surgery registry as of August 2023. Patients in the pREBOA-PRO group (n = 110) receiving partial occlusion in Zone 1 were contrasted to patients in the ER-REBOA group (n = 752) treated with complete occlusion in Zone 1. Between-group comparisons included demographics, clinical presentation, aortic occlusion strategy, clinical complications, and mortality. Results: Demographics, clinical presentation, and mortality were indistinguishable between groups, except for age which was higher in the ER-REBOA group (44 vs. 38, P < 0.002). The partial aortic occlusion strategy was employed more often in the pREBOA-PRO group (87% vs. 33%, P < 0.05) and for longer periods (59 min vs. 50 min, P < 0.003). In contrast, AKI occurred less frequently in the pREBOA-PRO group (19% vs. 33%, P < 0.05). Conclusions: The more frequently partial and longer occlusion times in Zone 1 with the use of pREBOA-PRO resulted in lower AKI incidence suggesting that this newer device is a safer extended bridge to hemorrhage control.
No takes yet. Share an insight, caveat, or question.
Vassy et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: